RHEOS MEDICINES, INC. — Form D/A
RHEOS MEDICINES, INC. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2018-10-05. $21.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-10-05
- Form: D/A
- Accession: 0001735905-18-000003
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $21.0M
- Investors: 1
- Date of first sale: 2018-03-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-309382
Issuer
- Name: RHEOS MEDICINES, INC.
- CIK: 0001735905
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 38 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Phone: 857-777-4242
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| ABBIE CELNIKER | Director | Mt. Arlington, NJ |
| ABBIE CELNIKER | Executive Officer | Mt. Arlington, NJ |
| Cary Pfeffer | Director | Boston, MA |
| Dan Matloff | Executive Officer | Waltham, MA |
| Jeffrey Bluestone | Director | South San Francisco, CA |
| Sanjay Keswani | Director | South San Francisco, CA |
| Sanjay Keswani | Executive Officer | South San Francisco, CA |
| Gad Soffer | Executive Officer | CAMBRIDGE, MA |
| Ryan Cohlhepp | Executive Officer | CAMBRIDGE, MA |
| J. Duncan Higgons | Director | CAMBRIDGE, MA |
| Stephen Sherwin | Director | CAMBRIDGE, MA |
Other filings by this issuer (2)
More